[A 30-month study of the calls to the Regional Drug Monitoring Center in Lorraine (Nancy)].
For over a period of 30 months, all the questions to the French "Centre de Pharmacovigilance" of Nancy Lorraine have been analysed. The University Hospital of Nancy is by for the main caller (65%) and the suspicion of adverse drug reaction represents 61% of all the questions. Gastrointestinal and hepatic disorders, cardiovascular drugs arouse the greatest number of questions. Comparison with results previously published by some French Pharmacovigilance Centres points out some regional particularities.
Trechot
P F
PF
Centre de Pharmacovigilance de Lorraine, Hôpital Central, Nancy.
Royer
R J
RJ
Gaire
M
M
Gaspard
M C
MC
Netter
P
P
D005602:France; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires / Q000145:classification
Etude sur 30 mois de la répartition des appels au Centre Régional de Pharmacovigilance de Lorraine (Nancy).